Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription 01.07.2024 3 AJNR Am J Neuroradiol 1 Am J Clin Oncol 1 BMC Cancer 2 Childs Nerv Syst 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 5 J Neurooncol 1 Nat Rev Cancer 5 Neuro Oncol 2 Neurosurgery 1 Pediatr Neurol 1 PLoS One 1 Radiologia (Engl Ed)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. AZIZOVA A, Prysiazhniuk Y, Wamelink IJHG, Petr J, et al
   Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance.
   AJNR Am J Neuroradiol. 2024 Jun 27. doi: 10.3174/ajnr.A8274.
   PubMed         Abstract available
   
   
2. ELLINGSON BM, Sanvito F, Cloughesy TF, Huang RY, et al
   A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
   AJNR Am J Neuroradiol. 2024 Jun 26:ajnr.A8396. doi: 10.3174/ajnr.A8396.
   PubMed         Abstract available
   
   
3. BAO Y, Qiu S, Li Z, Yang G, et al
   Preoperative assessment of meningioma consistency using a combination of magnetic resonance elastography and diffusion tensor imaging.
   AJNR Am J Neuroradiol. 2024 Jun 21:ajnr.A8385. doi: 10.3174/ajnr.A8385.
   PubMed         Abstract available
   
   

   
   Am J Clin Oncol

4. JANOPAUL-NAYLOR JR, Patel JS, Rupji M, Qian DC, et al
   Patterns of Treatment Failure in Primary Central Nervous System Lymphoma.
   Am J Clin Oncol. 2024;47:333-338.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. LI YA, Zhao C, Ge JJ, Li C, et al
   Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy.
   BMC Cancer. 2024;24:754.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

6. BISWAS A, Rao HR, Wagner MW
   Pediatric-type diffuse low-grade gliomas.
   Childs Nerv Syst. 2024 Jun 26. doi: 10.1007/s00381-024-06500.
   PubMed         Abstract available
   
   
7. KARBE AG, Gorodezki D, Schulz M, Tietze A, et al
   Surgical options of chiasmatic hypothalamic glioma-a relevant part of therapy in an interdisciplinary approach for tumor control.
   Childs Nerv Syst. 2024 Jun 25. doi: 10.1007/s00381-024-06498.
   PubMed         Abstract available
   
   

   
   Int J Cancer

8. GANSER K, Stransky N, Abed T, Quintanilla-Martinez L, et al
   K(Ca) channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by K(Ca) expression levels.
   Int J Cancer. 2024 Jun 27. doi: 10.1002/ijc.35064.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

9. SHEEHAN J, Trifiletti D, Keole S
   Unlocking the Power of Connectomes for Image-Guided Cranial Interventions.
   Int J Radiat Oncol Biol Phys. 2024;119:1133-1136.
   PubMed        
   
   

   
   J Neurooncol

10. GUIDARA S, Seyve A, Poncet D, Leonce C, et al
    Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.
    J Neurooncol. 2024 Jun 27. doi: 10.1007/s11060-024-04733.
    PubMed         Abstract available
    
    
11. IANNALFI A, Riva G, Lillo S, Ciccone L, et al
    Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes.
    J Neurooncol. 2024 Jun 25. doi: 10.1007/s11060-024-04751.
    PubMed         Abstract available
    
    
12. ERSOY TF, Brainman D, Coras R, Berger B, et al
    Defining the role of surgery for patients with multiple brain metastases.
    J Neurooncol. 2024 Jun 25. doi: 10.1007/s11060-024-04739.
    PubMed         Abstract available
    
    
13. ROUX A, Elia A, Hudelist B, Benzakoun J, et al
    Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.
    J Neurooncol. 2024 Jun 24. doi: 10.1007/s11060-024-04747.
    PubMed         Abstract available
    
    
14. PARK J, Kim YJ, Lee M, Kim D, et al
    Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis.
    J Neurooncol. 2024 Jun 22. doi: 10.1007/s11060-024-04750.
    PubMed         Abstract available
    
    

    
    Nat Rev Cancer

15. REMSIK J, Boire A
    The path to leptomeningeal metastasis.
    Nat Rev Cancer. 2024;24:448-460.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

16. ABU-ARJA MH, Brown AL, Su JM, Okcu MF, et al
    The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
    Neuro Oncol. 2024 Jun 25:noae114. doi: 10.1093.
    PubMed         Abstract available
    
    
17. NAKASE T, Guerra GA, Ostrom QT, Ge T, et al
    Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes.
    Neuro Oncol. 2024 Jun 25:noae112. doi: 10.1093.
    PubMed         Abstract available
    
    
18. SONKSEN M, Obrecht-Sturm D, Hernaiz Driever P, Sauerbrey A, et al
    Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies.
    Neuro Oncol. 2024 Jun 26:noae111. doi: 10.1093.
    PubMed         Abstract available
    
    
19. VAN DEN BENT MJ, French PJ, Brat D, Tonn JC, et al
    The biological significance of tumor grade, age, enhancement and extent of resection in IDH mutant gliomas: how should they inform treatment decision in the era of IDH inhibitors? Invited review.
    Neuro Oncol. 2024 Jun 24:noae107. doi: 10.1093.
    PubMed         Abstract available
    
    
20. LIU SJ, Raleigh DR, de Groot JF
    Proteasome inhibition for glioblastoma: lessons learned and new opportunities.
    Neuro Oncol. 2024 Jun 27:noae118. doi: 10.1093.
    PubMed        
    
    

    
    Neurosurgery

21. NAWABI NLA, Emedom-Nnamdi P, Kilgallon JL, Gerstl JVE, et al
    Assessing Mobility in Patients With Glioblastoma Using Digital Phenotyping-Piloting the Digital Assessment in Neuro-Oncology.
    Neurosurgery. 2024 Jun 24. doi: 10.1227/neu.0000000000003051.
    PubMed         Abstract available
    
    
22. GENDREAU J, Mehkri Y, Kuo C, Chakravarti S, et al
    Clinical Predictors of Overall Survival in Very Elderly Patients With Glioblastoma: A National Cancer Database Multivariable Analysis.
    Neurosurgery. 2024 Jun 28. doi: 10.1227/neu.0000000000003072.
    PubMed         Abstract available
    
    

    
    Pediatr Neurol

23. VERMA K, Hardy D
    Two Cases of Pediatric Leucine-Rich Glioma-Inactivated Protein-1 Encephalitis: Clinical Course, Challenges, and Implications.
    Pediatr Neurol. 2024;157:96-99.
    PubMed         Abstract available
    
    

    
    PLoS One

24. ZHENG K, Murphy MC, Camerucci E, Plitt AR, et al
    Improved quantification of tumor adhesion in meningiomas using MR elastography-based slip interface imaging.
    PLoS One. 2024;19:e0305247.
    PubMed         Abstract available
    
    

    
    Radiologia (Engl Ed)

25. PONS-ESCODA A, Majos C, Smits M, Oleaga L, et al
    Presurgical diagnosis of diffuse gliomas in adults: Post-WHO 2021 practical perspectives from radiologists in neuro-oncology units.
    Radiologia (Engl Ed). 2024;66:260-277.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.